Last reviewed · How we verify

NCT02884830

Nocturnal Continuous Positive Airway Pressure in Chronic Obstructive Pulmonary Disease Patients

Withdrawn NA Last updated 29 January 2020
What this trial tests

NA trial testing continuous positive airway pressure in Chronic Obstructive Pulmonary Disease. Withdrawn.

Timeline
7 January 2019
Primary endpoint
31 December 2019
31 December 2019

Quick facts

Lead sponsorCentre Hospitalier Universitaire Saint Pierre
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Start date7 January 2019
Primary completion31 December 2019
Estimated completion31 December 2019

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire Saint Pierre

Who can join

Adults 18 to 100, any sex, with Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Static hyperinflation is frequent in Chronic obstructive pulmonary disease (COPD) , resulting in increased end expiratory lung volume and positive end expiratory pressure (PEEPi) at the end of a normal expiration. Static hyperinflation worsens the work of breathing is increases patient's dyspnea. The application of a continuous positive airway pressure (CPAP) has been shown to improve static hyperinflation and to decrease the work of breathing. Sleep is deteriorated in COPD patients, and causal factors includes static hyperinflation. The purpose of our study is to assess the effect of nocturnal CPAP on sleep quality and functional respiratory parameters.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of continuous positive airway pressure

Trials testing the same drug.

Other recruiting trials for Chronic Obstructive Pulmonary Disease

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire Saint Pierre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02884830.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing